Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Filings indexed 436 across all filing types
Latest filing 2019-06-14 Regulatory Filings
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1485 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a specific, brief announcement regarding a 'Price Monitoring Extension' for trading, which is a type of regulatory market notice. This does not fit the definitions for formal financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Since it is a general regulatory announcement provided via the RNS service that doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings fallback category (RNS).
2019-06-14 English
Share Subscription and Issue of Equity to Vulpes
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is an announcement from Scancell Holdings Plc dated June 13, 2019. The core content details a 'Share Subscription and Issue of Equity' to a specific fund, raising capital (£3,877,965.55) and issuing new ordinary shares. This directly relates to fundraising and capital structure changes. While it involves share issuance (SHA) and potentially management changes (appointment of a director), the primary action announced is the capital raise via share subscription. This fits best under 'Capital/Financing Update' (CAP). It is not a full 10-K, an ER, or a general RNS fallback, as it describes a specific corporate finance event.
2019-06-13 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1501 characters) and contains the header 'RNS Number : 4789A'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the FCA as a Primary Information Provider. This type of immediate, operational market announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing or announcement, fitting the 'RNS' category.
2019-05-29 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1484 characters) and contains an RNS Number (4772A) and is dated May 29, 2019. The content explicitly discusses a 'Price Monitoring Extension' and mentions that the information is provided by RNS, the news service of the London Stock Exchange, approved by the Financial Conduct Authority (FCA). This is a standard, brief regulatory announcement disseminated via the London Stock Exchange's news service, which fits the definition of a general regulatory filing or announcement that doesn't fit a more specific category like earnings, dividend, or director dealing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-05-29 English
Scancell and CRUK provide an update on SCIB2
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 4804Z' and is dated '20 May 2019'. It details an update on a clinical development partnership concerning a cancer immunotherapy (SCIB2) between Scancell Holdings Plc and Cancer Research UK. The content is an announcement providing operational and partnership updates, not a full financial report (like 10-K or IR) or a transcript. The presence of the RNS Number and the closing statement referencing 'RNS, the news service of the London Stock Exchange' strongly indicates this is a regulatory news service announcement. Since it is a specific operational/partnership update that doesn't fit perfectly into ER, CAP, or LTR, the most appropriate general regulatory filing category is RNS, which serves as the fallback for miscellaneous regulatory announcements.
2019-05-20 English
Clinical Advisory Board and Update on Modi-1
Board/Management Information Classification · 99% confidence The document begins with 'RNS Number : 5878Y' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory news service announcement. The content details the establishment of a Clinical Advisory Board and provides an operational update on the Modi-1 clinical program, which is typical of a general corporate update disseminated via RNS. Since it is not a full financial report (10-K, IR), a specific financial release (ER), or a proxy statement (DEF 14A), the most appropriate classification is the general regulatory filing category for such announcements.
2019-05-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.